Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients with refractory glaucomas, including cases where previous surgical treatment has failed, cases of POAG, and pseudoexfoliative or pigmentary glaucoma with open angles that are unresponsive to maximum tolerated medical therapy
You may not be if
Angle closure glaucoma where angle has not been surgically opened
Previous glaucoma shunt/valve in the target quadrant
Presence of conjunctival scarring, prior conjunctival surgery or other conjunctival pathologies (eg, pterygium) in the target quadrant
Active inflammation (eg, blepharitis, conjunctivitis, keratitis, uveitis)
Active iris neovascularization or neovascularization of the iris within six months of the surgical date
Anterior chamber intraocular lens
Presence of intraocular silicone oil
Vitreous present in the anterior chamber
Clareo Health | Real-world Evidence Study of XEN in Chinese Patients With Refractory Glaucoma
